Intellectual Property India Publishes Patent Application for 'Viroporins Blockers/Inhibitors As Anti-Influenza Agents' Filed by Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517064695 A) filed by Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd., Jerusalem, on July 7, for 'viroporins blockers/inhibitors as anti-influenza agents.'

Inventor(s) include Arkin, Isaiah; and Lahiri, Hiya.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "Pharmaceutical compositions including an Influenza A M2 protein channel blocker for treating or preventing virulence of an Influenza A, such as, H1N1 subtype resistant to aminoadamantane, in a subject, are provided. Further provided is a pharmaceutical composition comprising a blocker of Influenza A M2 protein channel for preventing Influenza A cell entry, uncoating and/or release from a cell."

The patent application was internationally filed on Dec. 14, 2023, under International application No.PCT/IL2023/051278.

Disclaimer: Curated by HT Syndication.